uses JavaScript to provide the best possible experience for our content, but your browser has it disabled. Learn how to enable it here.


Posted August 13, 2010

Recall of Male Enhancement Supplement Sold in National Stores

On August 9, 2010 the U.S. FDA announced that the company Prolatis' of Salt Lake City, Utah is conducting a voluntary recall of the company's product sold as Prolatis'. The FDA had informed the company that lab analysis found Prolatis’ to contain Sulfoaildenafil, an analogue of Sildenafil, an FDA-approved drug used as treatment for male Erectile Dysfunction (ED), making Prolatis’ an unapproved drug. The active drug ingredient is not listed on the product label. Product manufactured prior to August 9, 2010 is included in this recall.

Join today to unlock all member benefits including full access to all recalls & warnings

Join Now

Join now at